Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like Senseonics Prices $41 Million Underwritten Offering of Common Stock May 25, 2017 <b>Gottlieb</b> Lays Out Plans to Attract and Preserve Top Talent at the FDA July 17, 2017 Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017
Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017
